Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Dec 8, 2017 0.29 +3.57   
 Value Line VALU Dec 8, 2017 18.48 +2.33   
 Vanda Pharmaceuticals Inc VNDA Dec 8, 2017 14.15 +1.80   
 VanEck Vectors Biotech ETF BBH Dec 8, 2017 125.55 +1.89   
 VanEck Vectors Generic Drugs ETF GNRX Dec 8, 2017 22.87 0.00   
 VanEck Vectors Pharmaceutical ETF PPH Dec 8, 2017 58.02 +2.09   
 Vanguard Emerging Markets Gover VWOB Dec 8, 2017 80.16 -0.09   
 Vanguard International Dividend Appreciation ETF VIGI Dec 8, 2017 65.70 +0.61   
 Vanguard International High Dividend Yield ETF VYMI Dec 8, 2017 65.88 +0.72   
 Vanguard Natural Resources LLC VNRBP Dec 8, 2017 2.00 0.00   
 Vanguard Natural Resources Llc VNR Dec 8, 2017 0.20 0.00   
 Vanguard Natural Resources LLC VNRCP Dec 8, 2017 2.00 0.00   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Dec 8, 2017 2.26 0.00   
 Vanguard Short-Term Inflation-P VTIP Dec 8, 2017 49.49 -0.02   
 Vanguard Total International Bo BNDX Dec 8, 2017 55.18 +0.04   
 Vantage Energy Acquisition Corp. VEACW Dec 8, 2017 1.18 0.00   
 Vantage Energy Acquisition Corp. VEACU Dec 8, 2017 10.10 0.00   
 Vantage Energy Acquisition Corp. VEAC Dec 8, 2017 9.70 +0.21   
 Varex Imaging Corporation VREX Dec 8, 2017 37.55 -0.13   
 Varonis Systems, Inc. VRNS Dec 8, 2017 47.35 -1.97   
 Vasco Data Security International VDSI Dec 8, 2017 13.90 +2.96   
 Vascular Biogenics Ltd. VBLT Dec 8, 2017 6.60 0.00   
 Vascular Solutions VASC Dec 8, 2017 56.00 0.00   
 VBI Vaccines, Inc. VBIV Dec 8, 2017 4.23 +0.95   
 Vca Antech WOOF Dec 8, 2017 92.98 0.00   
 Veeco Instruments Inc VECO Dec 8, 2017 11.90 -18.77   
 VEON Ltd. VEON Dec 8, 2017 3.75 -1.57   
 Vera Bradley VRA Dec 8, 2017 11.66 +3.19   
 Veracyte Inc VCYT Dec 8, 2017 6.46 +0.78   
 Verastem Inc VSTM Dec 8, 2017 4.33 +9.07   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK